Arteaga, C. L., O’Neill, A., Moulder, S. L., Pins, M., Sparano, J. A., Sledge, G. W., & Davidson, N. E. (2008). A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer.

Arteaga, Carlos L., Anne O’Neill, Stacy L. Moulder, Michael Pins, Joseph A. Sparano, George W. Sledge, och Nancy E. Davidson. A Phase I-II Study of Combined Blockade of the ErbB Receptor Network With Trastuzumab and Gefitinib in Patients With HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer. 2008.

Arteaga, Carlos L., et al. A Phase I-II Study of Combined Blockade of the ErbB Receptor Network With Trastuzumab and Gefitinib in Patients With HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer. 2008.